Annual Total Expenses
$52.80 M
-$2.93 M-5.26%
September 30, 2024
Summary
- As of February 7, 2025, AVXL annual total expenses is $52.80 million, with the most recent change of -$2.93 million (-5.26%) on September 30, 2024.
- During the last 3 years, AVXL annual total expenses has risen by +$10.85 million (+25.87%).
- AVXL annual total expenses is now -5.26% below its all-time high of $55.73 million, reached on September 30, 2023.
Performance
AVXL Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$14.26 M
-$468.00 K-3.18%
September 30, 2024
Summary
- As of February 7, 2025, AVXL quarterly total expenses is $14.26 million, with the most recent change of -$468.00 thousand (-3.18%) on September 30, 2024.
- Over the past year, AVXL quarterly total expenses has dropped by -$468.00 thousand (-3.18%).
- AVXL quarterly total expenses is now -7.15% below its all-time high of $15.36 million, reached on December 31, 2022.
Performance
AVXL Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
AVXL Total Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -5.3% | -3.2% |
3 y3 years | +25.9% | +16.4% |
5 y5 years | +83.3% | +16.4% |
AVXL Total Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -5.3% | +25.9% | -7.2% | +26.3% |
5 y | 5-year | -5.3% | +83.3% | -7.2% | +90.0% |
alltime | all time | -5.3% | >+9999.0% | -7.2% | >+9999.0% |
Anavex Life Sciences Total Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | $52.80 M(-5.3%) | $14.26 M(-3.2%) |
Jun 2024 | - | $14.73 M(+22.3%) |
Mar 2024 | - | $12.05 M(+6.7%) |
Dec 2023 | - | $11.29 M(-10.7%) |
Sep 2023 | $55.73 M(+9.3%) | $12.65 M(-6.5%) |
Jun 2023 | - | $13.53 M(+0.7%) |
Mar 2023 | - | $13.44 M(-12.5%) |
Dec 2022 | - | $15.36 M(+0.5%) |
Sep 2022 | $50.99 M(+21.5%) | $15.28 M(+22.7%) |
Jun 2022 | - | $12.46 M(+8.2%) |
Mar 2022 | - | $11.52 M(-1.7%) |
Dec 2021 | - | $11.72 M(-4.3%) |
Sep 2021 | $41.95 M(+35.6%) | $12.25 M(+7.9%) |
Jun 2021 | - | $11.36 M(+27.0%) |
Mar 2021 | - | $8.94 M(-4.8%) |
Dec 2020 | - | $9.40 M(+25.2%) |
Sep 2020 | $30.94 M(+7.4%) | $7.51 M(-7.4%) |
Jun 2020 | - | $8.11 M(+5.3%) |
Mar 2020 | - | $7.70 M(+0.9%) |
Dec 2019 | - | $7.63 M(+21.6%) |
Sep 2019 | $28.81 M(+50.2%) | $6.27 M(-11.3%) |
Jun 2019 | - | $7.07 M(-12.3%) |
Mar 2019 | - | $8.07 M(+9.0%) |
Dec 2018 | - | $7.40 M(+27.3%) |
Sep 2018 | $19.18 M(+23.5%) | $5.81 M(+28.0%) |
Jun 2018 | - | $4.54 M(-4.0%) |
Mar 2018 | - | $4.73 M(+15.7%) |
Dec 2017 | - | $4.09 M(-21.0%) |
Sep 2017 | $15.54 M(+0.6%) | $5.18 M(+42.4%) |
Jun 2017 | - | $3.64 M(+1.2%) |
Mar 2017 | - | $3.59 M(+14.6%) |
Dec 2016 | - | $3.13 M(-52.2%) |
Sep 2016 | $15.45 M(+117.3%) | $6.56 M(+191.9%) |
Jun 2016 | - | $2.25 M(+4.3%) |
Mar 2016 | - | $2.15 M(-45.1%) |
Dec 2015 | - | $3.92 M(-1.1%) |
Sep 2015 | $7.11 M(+139.4%) | $3.97 M(+162.2%) |
Jun 2015 | - | $1.51 M(+76.3%) |
Mar 2015 | - | $858.30 K(+11.4%) |
Dec 2014 | - | $770.70 K(+20.5%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2014 | $2.97 M(+38.9%) | $639.40 K(-36.0%) |
Jun 2014 | - | $998.80 K(-2.2%) |
Mar 2014 | - | $1.02 M(+229.8%) |
Dec 2013 | - | $309.60 K(-78.9%) |
Sep 2013 | $2.14 M(-50.5%) | $1.47 M(+1065.4%) |
Jun 2013 | - | $126.00 K(-0.9%) |
Mar 2013 | - | $127.10 K(-69.4%) |
Dec 2012 | - | $415.40 K(-35.2%) |
Sep 2012 | $4.32 M(-30.1%) | $641.40 K(-7.9%) |
Jun 2012 | - | $696.30 K(-12.4%) |
Mar 2012 | - | $794.70 K(-63.7%) |
Dec 2011 | - | $2.19 M(+78.6%) |
Sep 2011 | $6.17 M(+9.3%) | $1.22 M(-25.1%) |
Jun 2011 | - | $1.63 M(-16.0%) |
Mar 2011 | - | $1.95 M(+42.3%) |
Dec 2010 | - | $1.37 M(-30.4%) |
Sep 2010 | $5.65 M(+19.3%) | $1.96 M(+50.7%) |
Jun 2010 | - | $1.30 M(-14.1%) |
Mar 2010 | - | $1.52 M(+72.4%) |
Dec 2009 | - | $880.00 K(-51.1%) |
Sep 2009 | $4.73 M(-10.2%) | $1.80 M(+43.3%) |
Jun 2009 | - | $1.26 M(+63.2%) |
Mar 2009 | - | $770.00 K(-15.0%) |
Dec 2008 | - | $905.80 K(-66.3%) |
Sep 2008 | $5.27 M(+234.0%) | $2.69 M(+169.9%) |
Jun 2008 | - | $995.00 K(+48.1%) |
Mar 2008 | - | $671.70 K(-32.0%) |
Dec 2007 | - | $987.50 K(-13.4%) |
Sep 2007 | $1.58 M(+6063.7%) | $1.14 M(+346.3%) |
Jun 2007 | - | $255.60 K(+51.4%) |
Mar 2007 | - | $168.80 K(+1272.4%) |
Dec 2006 | - | $12.30 K(+112.1%) |
Sep 2006 | $25.60 K(-72.1%) | $5800.00(+1.8%) |
Jun 2006 | - | $5700.00(+21.3%) |
Mar 2006 | - | $4700.00(-50.0%) |
Dec 2005 | - | $9400.00(-77.6%) |
Sep 2005 | $91.70 K(+532.4%) | $42.00 K(-8.1%) |
Jun 2005 | - | $45.70 K(0.0%) |
Mar 2005 | - | $45.70 K(+1014.6%) |
Dec 2004 | - | $4100.00 |
Sep 2004 | $14.50 K | - |
FAQ
- What is Anavex Life Sciences annual total expenses?
- What is the all time high annual total expenses for Anavex Life Sciences?
- What is Anavex Life Sciences annual total expenses year-on-year change?
- What is Anavex Life Sciences quarterly total expenses?
- What is the all time high quarterly total expenses for Anavex Life Sciences?
- What is Anavex Life Sciences quarterly total expenses year-on-year change?
What is Anavex Life Sciences annual total expenses?
The current annual total expenses of AVXL is $52.80 M
What is the all time high annual total expenses for Anavex Life Sciences?
Anavex Life Sciences all-time high annual total expenses is $55.73 M
What is Anavex Life Sciences annual total expenses year-on-year change?
Over the past year, AVXL annual total expenses has changed by -$2.93 M (-5.26%)
What is Anavex Life Sciences quarterly total expenses?
The current quarterly total expenses of AVXL is $14.26 M
What is the all time high quarterly total expenses for Anavex Life Sciences?
Anavex Life Sciences all-time high quarterly total expenses is $15.36 M
What is Anavex Life Sciences quarterly total expenses year-on-year change?
Over the past year, AVXL quarterly total expenses has changed by -$468.00 K (-3.18%)